Voyager Therapeutics (VYGR) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Voyager Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $298K of VYGR stock on the open market.
Get emailed when insiders cluster-buy stocks like VYGR
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
VYGR insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $45K | 1 |
| Q1 2026 | — | 0 | $253K | 10 |
| Q4 2025 | — | 0 | $37K | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Voyager Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $298K. 9 of 12 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Apr 3SEC | Alfred SandrockCEO, President | Sell Plan | 11,511472,549 held (−2%) | $3.87 | $45K | -36.7% | — |
| Feb 26SEC | Alfred SandrockCEO, President | Sell Plan | 14,197484,060 held (−3%) | $3.79 | $54K | -35.4% | — |
| Feb 26SEC | Robin SwartzCOO | Sell Plan | 6,458199,738 held (−3%) | $3.77 | $24K | -35.0% | — |
| Feb 26SEC | Nathan D. JorgensenCFO | Sell Plan | 4,668151,416 held (−3%) | $3.77 | $18K | -35.0% | — |
| Feb 26SEC | Todd Alfred CarterChief Scientific Officer | Sell Plan | 4,174145,718 held (−3%) | $3.76 | $16K | -34.8% | — |
| Feb 20SEC | Alfred SandrockCEO, President | Sell Plan | 11,732498,257 held (−2%) | $3.41 | $40K | -28.2% | — |
| Feb 20SEC | Robin SwartzCOO | Sell Plan | 3,882206,196 held (−2%) | $3.44 | $13K | -28.8% | — |
| Feb 20SEC | Todd Alfred CarterChief Scientific Officer | Sell Plan | 3,301149,892 held (−2%) | $3.44 | $11K | -28.8% | — |
| Feb 11SEC | Alfred SandrockCEO, President | Sell | 12,192509,989 held (−2%) | $3.78 | $46K | -35.2% | — |
| Feb 11SEC | Robin SwartzCOO | Sell | 4,569210,078 held (−2%) | $3.85 | $18K | -36.4% | — |
| Feb 11SEC | Todd Alfred CarterChief Scientific Officer | Sell | 3,525153,193 held (−2%) | $3.85 | $14K | -36.4% | — |
| Oct 7SEC | Nathan D. JorgensenCFO | Sell Plan | 7,666123,834 held (−6%) | $4.78 | $37K | -48.7% | — |
Insiders at Voyager Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Alfred SandrockCEO, President | — | $184K | Apr 3, 2026 | — |
| Robin SwartzCOO | — | $55K | Feb 26, 2026 | — |
| Nathan D. JorgensenCFO | — | $54K | Feb 26, 2026 | — |
| Todd Alfred CarterChief Scientific Officer | — | $41K | Feb 26, 2026 | — |
VYGR stock: common questions
Are Voyager Therapeutics, Inc. insiders buying VYGR stock?
In the past 12 months, 0 insiders reported open-market purchases of VYGR worth $0.
Are Voyager Therapeutics, Inc. insiders selling VYGR stock?
4 insiders reported sales worth $298K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is VYGR's 52-week range?
Over the past year VYGR has traded between $2.37 and $5.33. It last closed at $2.45 on Oct 9, 2026.